Patrice P. DENEFLE, Ph.D, HDR, CEDEP INSEAD, is the former Head and General Manager of INSTITUT ROCHE and is currently serving as a Senior Advisor at LINKS CONSULTING. He also served as a Senior Vice President for DIGITAL & TRANSLATIONAL SCIENCES at IPSEN, an International Mid-size Biopharmaceutical company from 2010-2014. He has been previously in charge of multiple leadership positions in Innovation-driving programs in Large Pharma (Sanofi-Aventis, Aventis, RPR Gencell, RPR for 23 years), Biotechs (Genethon for 3 yrs) and mid-size Biopharma. Prof. Patrice P. DENEFLE received his Ph.D in Microbiology from Univ. Paris VII, Doctorate (HDR) in Pharmacology from Univ. Lille II. He is a qualified Professor in Molecular Biology (Sect 64) & Cell Biology (Sect 65), Associate Professor at Paris-Descartes University and lecturer in several ParisTech Graduate Schools. Prof. Patrice DENEFLE has published more than 150 scientific papers and patents. He is currently a member of several boards, R&D Strategic Committee of the MEDICEN Biocluster and the Research and Innovation Association of Health Industries (ARIIS) where he has been recently nominated President of the AI/Health strategic transformation Committee (CSF).
Apply state of the art Digital & Translational Sciences to bring Life Changing and Disease-Modifying Therapeutics to patients. Specialties: Broad and applied expertise in Biotechnology & Biotherapeutics, Lipid Biology & Atherosclerosis, Neurodegenerative Diseases, Oncology, Rare Diseases, Genetic Therapies, Human Genetics & Pharmacogenetics, Functional Genomics, Molecular and Clinical Pharmacology, Translational Research and Development, Precision Medicine (when Science meets Medicine).